The Potential Of Autologous Patient-Derived Circulating Extracellular Vesicles To Improve Drug Delivery In Rheumatoid Arthritis.
Moskovitch O, Anaki A, Caller T, Gilburd B, Segal O, Gendelman O, Watad A, Mehrian-Shai R, Mintz Y, Segev S, Shoenfeld Y, Popovtzer R, Amital H, Halpert G.
Moskovitch O, et al. Among authors: gendelman o.
Clin Exp Immunol. 2025 Jan 4:uxae101. doi: 10.1093/cei/uxae101. Online ahead of print.
Clin Exp Immunol. 2025.
PMID: 39756417